Last €16.74 EUR
Change Today -0.043 / -0.26%
Volume 0.0
WX8 On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 1:48 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

biomed realty trust inc (WX8) Snapshot

Open
€16.84
Previous Close
€16.78
Day High
€16.84
Day Low
€16.74
52 Week High
08/21/14 - €16.92
52 Week Low
12/12/13 - €12.98
Market Cap
3.3B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
195.1M
EX-Date
06/26/14
P/E TM
--
Dividend
€0.97
Dividend Yield
4.31%
Current Stock Chart for BIOMED REALTY TRUST INC (WX8)

Related News

No related news articles were found.

biomed realty trust inc (WX8) Related Businessweek News

No Related Businessweek News Found

biomed realty trust inc (WX8) Details

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. Its tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies, and other entities involved in the life science industry. The company owns or has interests in 72 properties, representing 119 buildings with approximately 11.0 million rentable square feet. Its properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania, and New York/New Jersey. The company qualifies as a REIT for federal income tax purposes. It would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. BioMed Realty Trust was founded in 2004 and is based in San Diego, California.

235 Employees
Last Reported Date: 02/10/14
Founded in 2004

biomed realty trust inc (WX8) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $760.0K
President and Chief Operating Officer
Total Annual Compensation: $567.5K
Chief Financial Officer
Total Annual Compensation: $420.0K
Executive Vice President of Real Estate
Total Annual Compensation: $410.0K
Executive Vice President and Director
Total Annual Compensation: $125.0K
Compensation as of Fiscal Year 2013.

biomed realty trust inc (WX8) Key Developments

BioMed Realty Trust Inc. Signs New Lease with GlycoMimetics, Inc

BioMed Realty Trust Inc. announced the signing of new lease with GlycoMimetics Inc. for one building comprising approximately 33,800 square feet at the Center for Life Science | Shady Grove in Rockville, Maryland. GlycoMimetics completed its initial public offering in January 2014 and has signed a partnership with Pfizer for a treatment for sickle cell disease which is about to begin Phase 3 trials. GlycoMimetics will be moving to the Center for Life Science Shady Grove, a four building campus with approximately 214,700 square feet or laboratory and office space.

BioMed Realty Trust Inc. Announces Expansion of Building

BioMed Realty Trust Inc. announced that the BioMed Realty Research Center. This development of an additional 122,000 square feet of laboratory and office space at 500 Fairview in South Lake Union is an expansion of the current building located at 530 Fairview. The company Research Center will be approximately 223,000 square feet of life science real estate, comprised of the new 122,000 square foot building and the current 101,000 square feet of world-class laboratory and office space currently at 530 Fairview, which is currently 100% leased to Novo Nordisk, NanoString Technologies and Presage Biosciences. The expanded BioMed Realty Research Center will be an institutional grade, class A+ lab and office building. Tenants will enjoy a full range of amenities within the Center and throughout the vibrant South Lake Union neighborhood, including onsite parking, fitness center and 100-person conference center. Tenants will also experience great views of Lake Union along with easy access to downtown, to public transportation and to Interstate 5.

BioMed Realty Trust Inc. Announces Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Earnings Guidance for the Year 2014

BioMed Realty Trust Inc. announced unaudited consolidated financial results for the second quarter and six months ended June 30, 2014. For the quarter, the company’s total revenues were $171,161,000 compared to $159,639,000 a year ago. Income from operations was $41,212,000 compared to $41,625,000 a year ago. Net income was $19,098,000 compared to $15,037,000 a year ago. Net income attributable to the company was $18,636,000 compared to $14,803,000 a year ago. Net income available to common stockholders was $18,636,000 compared to $14,803,000 a year ago. Income from continuing operations per share available to common stockholders basic and diluted earnings per share was $0.10 compared to $0.08 a year ago. Diluted FFO available to common shares and units was $83,378,000 or $0.40 per share compared to $80,514,000 or $0.41 per share a year ago. AFFO available to common shares and units was $67,322,000 or $0.32 per share compared to $73,951,000 or $0.37 per share a year ago. For the six month, the company’s total revenues were $340,037,000 compared to $320,090,000 a year ago. Income from operations was $81,964,000 compared to $88,495,000 a year ago. Net income was $39,865,000 compared to $32,497,000 a year ago. Net income attributable to the company was $37,469,000 compared to $32,118,000 a year ago. Net income available to common stockholders was $37,469,000 compared to $23,194,000 a year ago. Income from continuing operations per share available to common stockholders basic and diluted earnings per share was $0.19 compared to $0.13 a year ago. Diluted FFO available to common shares and units was $166,760,000 or $0.81 per share compared to $151,847,000 or $0.83 per share a year ago. AFFO available to common shares and units was $146,832,000 or $0.70 per share compared to $155,376,000 or $0.83 per share a year ago. For the year 2014, the company projected net income per diluted share available to common stockholders between $0.26 to $0.30, FFO per diluted share between $1.50 to $1.54 and CFFO per diluted share between $1.51 to $1.55. The company expects real estate depreciation and amortization of $1.26.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WX8:GR €16.74 EUR -0.043

WX8 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alexandria Real Estate Equities Inc $78.93 USD -0.02
American Campus Communities Inc $39.43 USD +0.16
Douglas Emmett Inc $28.37 USD +0.09
Equity Lifestyle Properties Inc $45.34 USD +0.19
Home Properties Inc $64.07 USD +0.39
View Industry Companies
 

Industry Analysis

WX8

Industry Average

Valuation WX8 Industry Range
Price/Earnings 86.6x
Price/Sales 6.7x
Price/Book 1.5x
Price/Cash Flow 14.6x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMED REALTY TRUST INC, please visit www.biomedrealty.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.